Financials

  • Market Capitalization 764.14 M
  • Employee 174
  • Founded 1996
  • CEO N/A
  • Website www.rigel.com
  • Headquarter Delaware, United States
  • FIGI BBG000BPWTW7
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
1.4
Price to sales ratio
1.7

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
2632
ZVRA
Zevra Therapeutics, Inc. - Common Stock
13.18 USD-1.27%-5.79%+2.89%+23.87%779.14 M USD
2640
SPRY
ARS Pharmaceuticals, Inc. - Common Stock
7.74 USD-2.52%-8.40%-21.42%-15.96%768.61 M USD
2650
CLYM
Climb Bio, Inc. - Common Stock
13.21 USD-5.64%+0.30%+13.29%+141.50%756.41 M USD
2672
OMER
Omeros Corporation - Common Stock
10.01 USD-2.63%-3.29%+13.49%+152.78%724.48 M USD

Frequently asked questions about Rigel Pharmaceuticals, Inc. - Common Stock

What is the Rigel Pharmaceuticals, Inc. - Common Stock stock price today?

The current price of Rigel Pharmaceuticals, Inc. - Common Stock (RIGL) is 41.3. Over the past 24 hours, the stock has changed by -2.94%. Follow the RIGL chart for real-time price dynamics.

What is the stock ticker of Rigel Pharmaceuticals, Inc. - Common Stock?

Rigel Pharmaceuticals, Inc. - Common Stock trades under the ticker RIGL. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Rigel Pharmaceuticals, Inc. - Common Stock stock going up?

RIGL has changed by +1.57% over the last week, +24.25% over the last month, and +37.07% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Rigel Pharmaceuticals, Inc. - Common Stock net income for the last quarter?

Rigel Pharmaceuticals, Inc. - Common Stock reported net income of 8.65 M for the last quarter. The previous quarter showed 268.06 M, which means net income changed by -96.77%.

How many employees does Rigel Pharmaceuticals, Inc. - Common Stock have?

As of the latest available data, Rigel Pharmaceuticals, Inc. - Common Stock has 174 employees. Workforce size can provide additional context about the company's scale and operations.

What is Rigel Pharmaceuticals, Inc. - Common Stock EBITDA?

Rigel Pharmaceuticals, Inc. - Common Stock EBITDA is 12.48 M, and its EBITDA margin is 21.22%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Rigel Pharmaceuticals, Inc. - Common Stock stock?

You can buy Rigel Pharmaceuticals, Inc. - Common Stock (RIGL) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Rigel Pharmaceuticals, Inc. - Common Stock stock?

Investing in Rigel Pharmaceuticals, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the RIGL chart and related analysis on metatrader.com as part of your research.

News